This is a preview of subscription content, log in via an institution to check access.
Reference
Fan SJ, et al. Health service utilization and medical costs among patients with schizophrenia receiving long-acting injectable risperidone versus oral risperidone: a nationwide retrospective matched cohort study in Taiwan. International Clinical Psychopharmacology : 27 Feb 2018. Available from: URL: http://doi.org/10.1097/YIC.0000000000000213
Rights and permissions
About this article
Cite this article
Comparing resource use and costs in Taiwan: LAI vs oral risperidone. PharmacoEcon Outcomes News 798, 11 (2018). https://doi.org/10.1007/s40274-018-4758-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-4758-9